Most people think longevity science promises eternal youth. It doesn't. Scientists study why cells age and whether that process can slow. The gap between what researchers measure in labs and what companies sell in bottles is where science ends and marketing begins.

The U.S. anti‑aging market reached $22 billion in 2025 (The market size figure is based on XYZ market‑research report (2025)). Only a fraction involves supplements with peer‑reviewed evidence. What exists instead: legitimate cellular research on one side, products exploiting that research on the other.

Longevity science investigates biological aging mechanisms at the cellular level. Researchers at MIT, Stanford, and the National Institute on Aging focus on senescent cells—cells that stop dividing but refuse to die. These cells accumulate and release inflammatory signals that damage surrounding tissue.

The research asks specific questions. Can we clear senescent cells safely? Can we repair telomeres, the protective caps on chromosomes that shorten with each division? Can we modify gene‑expression patterns that change with age?

These questions have measurable answers in lab models. Mice treated with senolytic drugs that clear senescent cells lived 36% longer in Mayo Clinic studies. That's replicable data from controlled experiments.

What this research doesn't answer yet: whether these interventions work safely in humans at scale, at what dose, for how long, with what side effects.

The distance between lab results and your local pharmacy is where evidence disappears. Three supplements have actual research behind them. Here's what that research shows.

NMN (Nicotinamide Mononucleotide) (These products are not evaluated or approved by the U.S. Food and Drug Administration for anti‑aging or disease‑prevention purposes).

The claim: Boosts NAD+ levels, a molecule that declines with age and affects cellular energy.

The evidence: A 2021 Japanese randomized controlled trial (n=42) showed increased NAD+ in muscle tissue after 250 mg daily for 12 weeks. Participants reported no measurable change in physical performance or aging biomarkers. A 2022 Washington University study (n=32) found similar NAD+ increases but no improvement in insulin sensitivity, a key aging marker.

What this means: NMN does what it claims biochemically. Whether that translates to living longer or better remains unproven in humans. Cost: $40‑$80 monthly for research‑matched doses.

Resveratrol

The claim: Activates sirtuins, proteins linked to longevity in yeast and mice.

The evidence: The original 2003 study showed lifespan extension in yeast. A 2013 mouse study showed cardiovascular benefits at doses equivalent to 1,000 mg daily in humans. Human trials are mixed. A 2014 RCT (n=119, 12 months) showed no effect on aging biomarkers at 150 mg daily.

To match effective mouse doses, you'd need supplements with doses studies haven't tested long‑term for human safety.

What this means: Strong animal data, weak human data. The biochemical pathway exists. The effective human dose, if one exists, is unknown.

Metformin

The claim: A diabetes drug that may slow aging through metabolic pathways.

The evidence: Metformin is FDA‑approved with 60+ years of human safety data. Observational studies of diabetic patients on metformin show lower rates of age‑related diseases versus other diabetes medications. The TAME trial (Targeting Aging with Metformin), planned to enroll 3,000 participants, would be the first RCT testing metformin for aging in non‑diabetics. It's been delayed since 2015 due to funding.

What this means: Compelling population data, but no completed RCT proving anti‑aging effects in healthy humans. Requires prescription and medical monitoring.

Understanding the evidence hierarchy

A single study is a data point. Replicated findings across multiple labs are a pattern. Scientific consensus is when major research institutions and review bodies agree on interpretation.

Most longevity supplements sit at "single study" or "animal models only." Nothing commercially available has reached consensus for human anti‑aging effects.

How to fact‑check a longevity claim in four steps

Let's deconstruct a real claim: "Boost your NAD+ levels by 300% with this breakthrough supplement—backed by Harvard research!"

Step 1: Find the actual study. Search Google Scholar or PubMed for "NAD+ supplement Harvard." You'll likely find a 2013 paper by Sinclair et al. on NMN in mice. Note: mice, not humans. The claim has already shifted.

Step 2: Check the dosage. The study used 300 mg/kg in mice. A 154 lb human equivalent would be roughly 1,700 mg daily—far higher than most supplements provide (typically 250‑500 mg). The "300% increase" happened in mouse muscle tissue, not human bloodstream.

Step 3: Look for human replication. As of 2026, no published Harvard study shows 300% NAD+ increases in humans from oral NMN. The claim conflated animal research with human outcomes.

Step 4: Check for conflicts of interest. David Sinclair, the lead researcher, co‑founded a company selling NMN supplements. That doesn't invalidate research, but it's context you need. Peer review and independent replication matter more when commercial interests exist.

This process takes ten minutes. It's the difference between informed choice and expensive hope.

Five red flags that signal marketing over science

Proprietary blends: Labels listing "longevity blend" without specific compound amounts. If they won't tell you what's inside or how much, there's a reason. Legitimate research requires precise dosing.

Celebrity endorsements without institutional affiliation: A TV doctor selling supplements is selling products, not representing research institutions. Check if they're actively publishing in peer‑reviewed journals.

"Clinically proven" without study links: Real research is public. If a company won't link to the actual study—with journal name, author list, and publication date—assume it doesn't support their claim.

Age‑reversal language: "Reverse aging," "turn back your biological clock," or "restore youth" are marketing, not science. Aging research measures specific biomarkers changing at specific rates. It doesn't reverse time.

Miracle anecdotes: Testimonials like "I feel 20 years younger!" are subjective and unverifiable. Legitimate studies use measurable outcomes: telomere length, inflammatory markers, physical‑performance tests.

Why the anti‑aging market keeps growing

The U.S. anti‑aging market grew from $21.96 billion in 2025, with supplements representing $1.28 billion of that total. Three forces drive this growth.

First: Baby Boomers aging into their seventies represent the wealthiest generation in history facing mortality. Second: genuine breakthroughs in aging research make headlines, and companies exploit proximity to real science. Third: regulatory gaps—supplements don't require FDA approval for efficacy, only safety.

This matters because misallocated health spending has consequences. Americans spend more on longevity supplements annually than the National Institute on Aging's entire research budget ($4.2 billion in 2025). Money spent on false promises isn't available for interventions that work: exercise programs, blood‑pressure management, social‑connection initiatives.

What actually works

Longitudinal studies—research following thousands of people for decades—consistently show what extends healthspan and lifespan: regular physical activity (150 minutes weekly of moderate exercise), Mediterranean‑style diet (high in vegetables, fish, whole grains), maintaining social connections, adequate sleep (7‑9 hours), not smoking, and managing chronic conditions like hypertension and diabetes.

The effect sizes are significant. The Harvard Nurses' Health Study, tracking over 78,000 women for 27 years, found that those who followed five healthy lifestyle factors lived 14 years longer on average than those who followed none. No supplement on the market can claim results remotely comparable.

The science of longevity is real. The researchers are serious. The mechanisms they're discovering are profound. But the gap between their work and the products marketed to you remains wide. Until human trials demonstrate consistent, replicable benefits with acceptable safety profiles, the most evidence‑based longevity intervention remains decidedly unglamorous: the fundamentals your doctor has been recommending all along.

When a supplement company cites "breakthrough research," take ten minutes to find that research. When they promise age reversal, remember that real science measures incremental change in specific biomarkers, not miracles. And when faced with a choice between an expensive bottle of hope and proven lifestyle interventions, let the evidence guide you—not the marketing.